University of Nebraska Medical Center — Omaha, Nebraska

Public research footprint of University of Nebraska Medical Center, compiled from the ClinicalTrials.gov public registry.

1,575

Registered studies

494

Active

243

Recruiting now

850

Completed

186

Stopped or withdrawn

Most-studied conditions

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Acute Myeloid Leukemia

Recently updated registry entries

NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT06997497 — A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Nebraska Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.